A new study found that two diversity-oriented programs supported by the NIH doubled the odds that an undergraduate would earn a Ph.D.
Vetenskapsnyheter
Luigi Mangione plans to assert a psychiatric defense at his state murder trial, claiming he was suffering from extreme emotional disturbance when he gunned down UnitedHealthcare CEO Brian Thompson.
More than 60 organizations are urging the FDA to withdraw approval for what they called the “unsafe” use of antibiotics for preventing disease in food-producing livestock.
UniQure will submit Huntington's therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech news
A cyber extortion group claimed to have stolen more than a terabyte of data from Novo Nordisk and said it is exploring selling some of the data
In this edition of AI Prognosis, Brittany Trang takes a close look at ambient scribe developer Abridge's claim about being patient-centered.
Infant mortality rate dips, OTC naloxone options rise, and other health news from Morning Rounds
The FDA has reversed its opposition to a closely watched experimental treatment for Huntington’s disease, clearing a path for its maker.
“‘Health care’ is such a big word for STAT. It’s a cornerstone of our coverage,” says STAT director of editorial operations Sarah Mupo.
“The privilege of oncology is not only that you get to cure people,” writes oncologist Khushali Jhaveri. “It is also that you are invited into the most honest rooms in…
“As a physician and former public health official, I have never been more concerned about those rates of congenital syphilis,” writes Jeffrey D. Klausner.
Should the federal government try to slow — or even block — U.S. biotech deals that could benefit China?
In this edition of STAT Health Tech: How a biotech startup turned a failed clinical trial into an AI model, and more.
The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations
Infant mortality in the U.S. dropped to a new all-time low in 2025, according to CDC data, though it still trails other similar nations.
A new AI model to improve trial enrollment, importing drugs from Canada, and more biotech news from The Readout
Weight loss drugs will be available through Medicare starting next month, thanks to a program that is supposed to be temporary but may be difficult to end
Medicare-funded weight loss, Utah's lower drunk driving limit, and more health news from Morning Rounds
STAT+: Verge Labs’ new AI model solves patient stratification problems for neurology clinical trials
As the saying goes, one man’s trash is another man’s treasure. Or as Verge Labs might put it, one company’s failed clinical trial … is that same company’s new AI…
As the Human Cell Atlas project marks its 10th anniversary, a leader's ties to a major single-cell RNA sequencing company raise conflict-of-interest questions.
America’s next health emergency won’t wait for Washington, write W. Craig Vanderwagen and Jennifer B. Alton.
“Alzheimer’s is not primarily a disease of old age. It is a decades-long biological process,” writes Elizabeth Bevins.
The FDA said it will allow Colorado to import certain prescription drugs from Canada in an effort to bring prices down for residents.
After July 1, Medicare will offer GLP-1 weight-loss drugs for $50. It's supposed to be temporary, but chances are it won't be.
A new analysis found that results for less than half of the clinical studies registered in a key European database were reported within the required time frame.
Covid vaccination was also tied to a nearly 24% reduction in all-cause cardiac events in a large study, surprising researchers.